Immortals Launches a $159 At-Home Vaginal Microbiome Test. It's Not FDA-Cleared.
A $159 swab test that maps your vaginal microbiome and screens for four STIs, with a doctor review. It's not FDA-cleared, and it doesn't diagnose.

Your microbiome, by mail
Gut microbiome tests have been sold by mail for years.
Now the same idea is coming for the vagina, with a $159 price tag and a launch post that starts like this: “Every day, I test my vaginal microbiome. It’s part of my $2.6M experiment.”
What the test does
The line comes from Kate Tolo, whom the company calls a co-founder of Immortals and of Blueprint, the longevity company run by Bryan Johnson. She announced the test on the Blueprint blog on October 28. Here’s what Immortals says you get:
- An at-home kit with a 20-second swab and a prepaid return bag
- A DNA read of 10,000+ bacteria and fungi, including how dominant Lactobacillus crispatus is, your bacterial and fungal load and every organism found
- Screening for four STIs, Mycoplasma genitalium, gonorrhea, chlamydia and trichomonas, which Immortals says comes at no extra cost
- Results written and reviewed by a board-certified physician, posted to a dashboard in 4 to 9 business days
- An optional $85 follow-up visit, where the doctor can prescribe treatment if appropriate
The kit costs $159 with free US shipping and is HSA and FSA eligible, according to the product page. It’s for adults 18 and older who were born with a vagina, and it isn’t available in New York.
A doctor-reviewed map of your vaginal microbiome is new. A diagnosis it is not.The WellWham perspective
Is it available now?
The Immortals product page lists the test at $159 with a Get Started button and shows it as available to order. The same page also displays a Notify Me When Available button, so the launch status is a little unclear. Check the page before you count on a kit shipping.
What Immortals says it is not
Immortals is unusually direct about the limits. On its product page, the company says the test is not FDA-cleared. It’s a laboratory-developed test, run in a CLIA-certified high-complexity lab, and “it is not a diagnostic device.” The page also says “detection is not the same as diagnosis.”
- It isn’t for use during pregnancy
- A positive gonorrhea result requires an in-person visit
- It doesn’t screen for cervical cancer or HPV, and it doesn’t replace a well-woman exam
Our read: the longevity crowd found women's health
This is our analysis. Women’s health is having a product moment, from menopause supplements to new hormone options like the first generic Climara Pro patch. Immortals brings the Blueprint playbook to it: test often, track everything, chart the data. Tolo says she tests daily to follow her cycle alongside 1,900 biomarkers, but she also writes that testing every 3 months is plenty to see how a specific change, like alcohol, a new partner or antibiotics, shows up in your results.
The reality check
A map of what lives in your vagina is not the same as a diagnosis, and Immortals says so itself. In the launch post, Tolo links the vaginal microbiome to issues including preterm birth, HIV risk, IVF outcomes, miscarriage and pelvic inflammatory disease. Those are her framing, and the post doesn’t cite studies for them. The STI screen is useful, but if you have symptoms, pain, unusual discharge or a positive result, see a clinician in person. And if you’re pregnant, this test isn’t for you.
The close
Tolo tests every day.
Her own post says every three months is plenty. Start with your doctor, and decide if a $159 map adds anything to that visit.
Sources
- Kate Tolo, “Vaginal microbiome test launch,” Blueprint blog, October 28, 2026: blueprint.bryanjohnson.com
- Immortals, Vaginal Microbiome Test product page, accessed October 29, 2026: immortals.com
Brand information: Immortals






